BDA-410 inhibits SARS-CoV-2 main protease activity and viral replication in mammalian cells

J Cell Mol Med. 2022 Oct;26(19):5095-5098. doi: 10.1111/jcmm.17442. Epub 2022 Sep 9.
No abstract available

Keywords: BDA-410; COVID-19; Calpain-1; SARS-CoV-2.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • COVID-19*
  • Coronavirus 3C Proteases
  • Humans
  • Mammals
  • Molecular Docking Simulation
  • SARS-CoV-2*
  • Sulfonamides
  • Virus Replication

Substances

  • Antiviral Agents
  • N-1-(hydroxy(3-oxo-2-phenyl-1-cyclopropen-1-yl)methyl)-2-methylpropyl-2-benzenesulfonylamino-4-methylpentanamide
  • Sulfonamides
  • 3C-like proteinase, SARS-CoV-2
  • Coronavirus 3C Proteases